Erickson Dumaual

Erickson Dumaual is a seasoned financial analyst with extensive experience across various companies, including Beckman Coulter Diagnostics as a Senior Financial Analyst on the Proposals Analysis Team since February 2023, and prior roles at Thermo Fisher Scientific and Ambry Genetics. At Ambry Genetics, Erickson served as Lead Clinical Operations Analyst and Lead Financial Analyst, focusing on revenue monitoring, financial and operational analysis, and supporting audits. Additional experience includes senior roles at DiaSorin Molecular LLC and Volt Workforce Solutions, where Erickson conducted forecasting, budgeting, financial modeling, and management reporting. Educational qualifications include an MBA in Finance from Cal State Fullerton and a B.S. in Molecular Cell Biology and Genetics from California State University, Long Beach.